Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis.
about
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expressionGuanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p56lck.A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells.Likelihood-Based Approach to Gene Set Enrichment Analysis with a Finite Mixture ModelHuman Immunodeficiency virus type 1 Nef potently induces apoptosis in primary human brain microvascular endothelial cells via the activation of caspasesHuman immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism.Inhibition of human immunodeficiency virus type 1 by triciribine involves the accessory protein nefMolecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineageSequence- and interactome-based prediction of viral protein hotspots targeting host proteins: a case study for HIV Nef.Nef alleles from all major HIV-1 clades activate Src-family kinases and enhance HIV-1 replication in an inhibitor-sensitive manner.Mechanisms of HIV-associated lymphocyte apoptosis: 2010HIV-1 Nef increases astrocyte sensitivity towards exogenous hydrogen peroxideHIV-1 gp120 protein downregulates Nef induced IL-6 release in immature dentritic cells through interplay of DC-SIGNHuman immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.DRAM triggers lysosomal membrane permeabilization and cell death in CD4(+) T cells infected with HIV.Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy.Overview of the purification of recombinant proteins.Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.Proteomic profiling of SupT1 cells reveal modulation of host proteins by HIV-1 Nef variantsT-cell and neuronal apoptosis in HIV infection: implications for therapeutic intervention.Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.Reconstructing the temporal progression of HIV-1 immune response pathways.Retinoblastoma protein induction by HIV viremia or CCR5 in monocytes exposed to HIV-1 mediates protection from activation-induced apoptosis: ex vivo and in vitro study.Retroviral proteomics and interactomes: intricate balances of cell survival and viral replication.HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells.Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.Role of p53 in neurodegenerative diseases.Genome guardian p53 and viral infections.Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIVMicroglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides.HIV-1 Nef and T-cell activation: a history of contradictions.Modulation of HIV pathogenesis and T-cell signaling by HIV-1 NefHIV-1 Nef: hacker of the host cell.Microarray study reveals that HIV-1 induces rapid type-I interferon-dependent p53 mRNA up-regulation in human primary CD4+ T cells.Characterization of Nef-CXCR4 interactions important for apoptosis induction.Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptorsOverview of the purification of recombinant proteins produced in Escherichia coli.Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction.Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
P2860
Q21245193-B5C11118-A798-4D7F-8D5E-2BAE371D61A3Q31112668-499FF50F-F192-4169-9615-5EE726835466Q33533765-BD5E6CC0-9DC7-49C2-A48F-FA584E0D00F1Q33689669-5FAFD006-462C-4E1A-BF13-53905FFD7FF0Q33707527-63A2C165-A1F1-43AE-A655-059CF24D1E71Q33755059-1D63984A-BEA5-49C7-BD16-BB64E8374EFEQ33768829-B98558B8-447D-4BD3-8DC0-F5E95DB49F92Q33864438-352A2D9F-0ABD-48D2-A6B9-80B173FF9B68Q33954592-62237732-F87B-4FA9-8F3F-A2701A2A64F1Q34185928-E03CFC9F-EE00-4E2A-B89E-A19D9D57B121Q34545417-FA585641-7B85-4CAF-840E-8759708A284FQ34573902-726BD1FD-C742-4B48-B873-4ED26503DE03Q34648685-DB6C38A8-3E44-4F52-B9A5-8B33842EFAE1Q34664366-8FD00B8E-63BC-461F-B4F1-2008AF081B33Q34711805-8C1FFBD1-8774-45A6-901E-E19FE9BD16AFQ34714816-92A9978B-46BD-465C-872A-C6F9CA8DD81FQ35541296-104D510A-0F49-4B9A-A493-D80C75326B83Q35596237-B500EF9B-5B52-4529-B169-1DB8392CB264Q35601697-FA8E462F-E238-4C67-B374-5B7F800ED0B4Q35613792-E87FE3FF-5516-4134-B0E2-A2F12C123282Q35666063-8E90F7AA-A8C8-4477-8B07-7B254129F6E8Q36499676-49EDB545-9197-4C14-BDD4-7241CFC45CE1Q37005470-2073CDFB-20C7-44D3-94CA-DA27BA198F49Q37131515-A945B548-A3A2-4217-B255-540C3F6A9F15Q37183096-CCB0C210-8B1F-4DB5-930C-E0B44BBA4188Q37485148-1FD0761B-CBFC-4F61-B1DF-DC091825E9F2Q37714039-4D9CAF54-B20F-4772-BD9D-44FE3A816876Q37951338-7BD3E0EF-6F0D-433D-894F-5C707796673CQ38068825-0190F536-E75B-417C-B6B5-6E04F68BBB54Q38070411-37FEF4B5-8D63-4ABA-A21D-454C2072F74DQ38814829-1C04FB7C-2740-4229-9FEB-58EB7D94DC6CQ39321661-93ADDEDD-E199-402B-A0A7-96D9E234BFDFQ39577894-AED73438-0FCA-401F-B68E-6DE44F121D22Q39658813-4D899501-FF64-4583-A87A-1E6613B50009Q39895000-8A176B2A-D727-4CA0-885B-AEAF2B6CA1C5Q40161550-FC21BEFF-A84D-4C60-884E-5038034955E7Q40584535-F28FCF6C-C1E3-44D3-BC2C-F6B724B3AD7EQ42169778-9132560C-793F-4ADE-8220-6C0D879EEB70Q44483444-D520F495-D83F-42E2-A162-4A8E2D528D65Q45325964-D97A0ECC-A67C-4C1B-AF71-98C7CFA8E37A
P2860
Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human immunodeficiency virus t ...... against p53-mediated apoptosis
@nl
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@ast
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@en
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@en-gb
type
label
Human immunodeficiency virus t ...... against p53-mediated apoptosis
@nl
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@ast
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@en
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@en-gb
prefLabel
Human immunodeficiency virus t ...... against p53-mediated apoptosis
@nl
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@ast
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@en
Human immunodeficiency virus t ...... gainst p53-mediated apoptosis.
@en-gb
P2093
P2860
P921
P3181
P1433
P1476
Human immunodeficiency virus t ...... against p53-mediated apoptosis
@en
P2093
Ahmed Azad
Alison L Greenway
Dale A McPhee
Gavan Holloway
John Mills
Paul Lambert
Sonia Sankovich
P2860
P304
P3181
P356
10.1128/JVI.76.6.2692-2702.2002
P407
P577
2002-03-01T00:00:00Z